Forum Health Appoints Sean Whelan as Chief Financial Officer
TL;DR
Sean Whelan's appointment as the new CFO will drive growth and financial stewardship at Forum Health, giving it a competitive edge.
Whelan will lead strategic financial initiatives, enhance operational efficiency, and guide investments in innovation and compliance at Forum Health.
Forum Health's personalized healthcare approach and Whelan's leadership will help deliver exceptional patient care and redefine healthcare.
Whelan has a distinguished career spanning over three decades, including successful IPO leadership and key roles in public companies.
Found this article helpful?
Share it with your network and spread the knowledge!
Forum Health, LLC, the first nationwide network of integrative and functional medicine providers, has appointed Sean Whelan as its new Chief Financial Officer. With a distinguished career spanning over three decades, including nearly two decades in healthcare services, Sean brings a proven track record and results-driven leadership to Forum Health. Learn more about Forum Health.
Phil Hagerman, Forum Health CEO, commented, "Mr. Whelan is an experienced financial executive with expertise in driving growth and leading transformation. His deep understanding of healthcare economics and commitment to financial stewardship will undoubtedly pilot Forum Health to the next phase of profitable growth."
In his new role as CFO, Whelan will lead strategic financial initiatives aimed at enhancing operational efficiency, mitigating risks, and fostering expansion in a dynamic healthcare environment. Additionally, he will implement robust financial planning, foster stakeholder relationships, and guide investments in innovation and compliance to ensure that Forum Health remains competitive and resilient while delivering superior patient care.
Expressing his enthusiasm, Sean Whelan stated, "I am honored to join such a talented, forward-thinking leadership team at Forum Health that is at the forefront of redefining healthcare. Together, we will continue to push the boundaries of what is possible and deliver exceptional outcomes for our patients, clinics, and many stakeholders."
Whelan's accomplished background includes CFO roles at InfuSystem Holdings (NYSE MKT: INFU), Diplomat Pharmacy (NYSE: DPLO), and Smile America Partners, and both CEO and CFO roles at Encore Rehabilitation Services. At Diplomat, he led the company’s successful 2014 Initial Public Offering and helped grow the business from $200 million to $4.5 billion during his tenure. He has held key leadership roles in closely held, private equity-backed, and public companies. Sean also presently serves on the Board of Directors of Zomedica (NYSE MKT: ZOM) and the University of Michigan’s Ross School of Business Alumni Board of Governors.
For more information about Forum Health and its services, please visit www.forumhealth.com.
Curated from News Direct
